732509318	732509318	CD	B-NP	O
|	|	NN	I-NP	O
BGH	BGH	NN	I-NP	O
|	|	NN	I-NP	O
00531532	00531532	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5897461	5897461	CD	B-NP	O
|	|	CC	I-NP	O
5/10/2006	5/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
non-cardiac	non-cardiac	JJ	I-NP	I-protein
syncope	syncope	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/3/2006	11/3/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/9/2006	8/9/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
WICKELL	WICKELL	NNP	B-NP	O
,	,	,	O	O
RON	RON	NNP	B-NP	O
108-95-46-4	108-95-46-4	CD	I-NP	O
Scot	Scot	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
8/6/06	8/6/06	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HABASH	HABASH	NN	B-NP	O
,	,	,	O	O
JAMAAL	JAMAAL	NNP	B-NP	O
FRANCES	FRANCES	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
PROTONIX	PROTONIX	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/6/06	8/6/06	CD	B-NP	O
by	by	IN	B-PP	O
CLOWSER	CLOWSER	NN	B-NP	O
,	,	,	O	O
DANE	DANE	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
336276429	336276429	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LAC-HYDRIN	LAC-HYDRIN	NN	I-NP	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
AMMONIUM	AMMONIUM	NN	I-NP	O
LACTATE	LACTATE	NN	I-NP	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
apply	apply	RB	B-ADVP	O
to	to	TO	B-PP	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

KEFLEX	KEFLEX	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
CEPHALEXIN	CEPHALEXIN	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
250	250	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
X	X	SYM	B-VP	O
5	5	CD	B-NP	O
doses	dose	NNS	I-NP	O
Starting	Start	VBG	B-VP	O
IN	IN	IN	B-PP	O
AM	AM	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/24	1/24	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
in	in	IN	B-PP	O
AM	AM	NN	B-NP	O
of	of	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
until	until	IN	B-PP	O
after	after	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
days	day	NNS	B-NP	O
of	of	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
give	give	VBP	B-VP	O
dose	dose	NN	B-NP	O
after	after	IN	B-SBAR	O
dialysis	dialysis	NN	B-NP	O
VASOTEC	VASOTEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/16/06	11/16/06	CD	B-NP	O
by	by	IN	B-PP	O
EPPING	EPPING	NNP	B-NP	O
,	,	,	O	O
AHMAD	AHMAD	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
VASOTEC	VASOTEC	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
482846068	482846068	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
COUGH	COUGH	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
ADVAIR	ADVAIR	NN	B-NP	O
DISKUS	DISKUS	NN	I-NP	O
250/50	250/50	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/6/06	8/6/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
SALMETEROL	SALMETEROL	NNP	I-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
18	18	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
50	50	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/27	10/27	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
please	please	VB	B-INTJ	O
give	give	VB	B-NP	O
1/2	1/2	CD	B-NP	O
prescribed	prescribe	VBN	I-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
pt	pt	JJ	B-NP	O
NPO	NPO	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-INTJ	O
give	give	VB	B-NP	O
1/2	1/2	CD	B-NP	O
prescribed	prescribe	VBN	I-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
pt	pt	NN	B-NP	B-protein
NPO	NPO	NN	I-NP	I-protein
.	.	.	O	O

INSULIN	INSULIN	NNP	B-NP	B-protein
NPH	NPH	NNP	I-NP	I-protein
HUMAN	HUMAN	NNP	I-NP	I-protein
25	25	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	I-protein
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q48H	Q48H	NN	I-NP	I-protein
X	X	SYM	B-VP	I-protein
5	5	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
Food/Drug	Food/Drug	NNP	B-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/6/06	8/6/06	CD	B-NP	O
by	by	IN	B-PP	O
ALVELO	ALVELO	NNP	B-NP	O
,	,	,	O	O
ARDEN	ARDEN	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COZAAR	COZAAR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LOSARTAN	LOSARTAN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
7	7	CD	B-NP	O
MICONAZOLE	MICONAZOLE	NN	I-NP	O
NITRATE	NITRATE	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
POWDER	POWDER	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
X	X	SYM	B-VP	O
14	14	CD	B-NP	O
doses	dose	NNS	I-NP	O
Starting	Start	VBG	B-VP	O
Today	Today	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
10/27	10/27	CD	I-NP	I-protein
-RRB-	-RRB-	NNPS	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
apply	apply	RB	B-ADVP	O
to	to	TO	B-PP	O
groin	groin	NN	B-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
other	other	JJ	I-NP	O
affected	affect	VBN	I-NP	O
areas	area	NNS	I-NP	O
NEPHROCAPS	NEPHROCAPS	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	B-protein
RX	RX	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
TRAMADOL	TRAMADOL	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	B-protein
Adv.	Adv.	NN	I-NP	I-protein
as	as	IN	B-PP	O
tol	tol	NN	B-NP	O
.	.	.	O	O

/	/	SYM	O	B-protein
2	2	CD	B-NP	I-protein
gm	gm	NN	I-NP	I-protein
Na	Na	NN	I-NP	I-protein
/	/	SYM	B-NP	I-protein
Renal	Renal	JJ	I-NP	I-protein
diet	diet	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FDI	FDI	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
ACTIVITY	ACTIVITY	NNP	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
Walking	Walking	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
DR	DR	NN	I-NP	O
BLACKMON	BLACKMON	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
466	466	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
824-6065	824-6065	CD	I-NP	O
6/28/06	6/28/06	CD	I-NP	O
@	@	SYM	B-NP	O
10	10	CD	I-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
AM	AM	VBP	B-VP	O
scheduled	scheduled	JJ	B-ADJP	O
,	,	,	O	O
VASC	VASC	NNP	B-NP	O
SURG	SURG	NNP	I-NP	O
DR	DR	NNP	I-NP	O
FLEER	FLEER	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
508	508	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
634-1402	634-1402	CD	I-NP	O
8/18/06	8/18/06	CD	I-NP	O
@	@	SYM	B-NP	O
1	1	CD	I-NP	O
:	:	SYM	I-NP	O
30	30	CD	I-NP	O
PM	PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
EP	EP	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Cards	Card	NNS	I-NP	B-protein
DR	DR	NN	I-NP	I-protein
RUEBEN	RUEBEN	NN	I-NP	I-protein
MIZENKO	MIZENKO	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
558	558	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
125-3500	125-3500	CD	I-NP	O
2/12/06	2/12/06	CD	I-NP	O
@	@	NN	I-NP	O
0930am	0930am	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Iic	Iic	NNP	B-NP	O
Valley	Valley	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
--	--	:	O	O
they	they	PRP	B-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
yuo	yuo	NN	B-NP	O
to	to	TO	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
you	you	PRP	B-NP	O
can	can	MD	B-VP	O
also	also	RB	I-VP	O
call	call	VB	I-VP	O
6	6	CD	B-NP	O
-	-	HYPH	I-NP	O
754-443-2399	754-443-2399	CD	I-NP	O
to	to	TO	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
earlier	earlier	RBR	B-ADVP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
FLUORESCEIN	FLUORESCEIN	NN	B-NP	O
DYE	DYE	NN	I-NP	O
,	,	,	O	O
TETRACYCLINE	TETRACYCLINE	NN	B-NP	O
ANALOGUES	ANALOGUES	NNS	I-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
syncope	syncope	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
non-cardiac	non-cardiac	JJ	I-NP	O
syncope	syncope	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	B-protein
Dx	Dx	NN	I-NP	I-protein
`	`	``	O	I-protein
89	89	CD	B-NP	I-protein
DM	DM	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
dependent	dependent	JJ	I-NP	O
Dx	Dx	NN	I-NP	O
`	`	``	O	O
89	89	CD	B-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
L	L	NN	I-NP	O
knee	knee	NN	I-NP	O
DJD	DJD	NN	I-NP	O
nephrotic	nephrotic	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
4/8	4/8	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
nephrotic	nephrotic	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
medullary	medullary	JJ	I-NP	O
CVA	CVA	NN	I-NP	O
7/4	7/4	CD	I-NP	O
right	right	JJ	I-NP	O
PICA	PICA	NN	I-NP	O
7/4	7/4	CD	I-NP	O
Echo-mod	Echo-mod	NN	I-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
WMA	WMA	NNP	I-NP	O
Anemia	Anemia	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
EP	EP	NN	B-NP	O
study	study	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
syncope	syncope	NN	B-NP	O
DDx	DDx	NN	I-NP	O
:	:	:	O	O
arrythmia	arrythmia	NN	B-NP	O
vs	vs	CC	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
vs	vs	IN	B-PP	O
vasovagal	vasovagal	JJ	B-NP	O
episode	episode	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
55yo	55yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
ESRD	ESRD	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
unresponsiveness	unresponsiveness	NN	B-NP	O
at	at	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
x2	x2	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
am	am	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
unresponsive	unresponsive	JJ	B-ADJP	O
,	,	,	O	O
CPR	CPR	NN	B-NP	B-protein
initiated	initiate	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
spontaneous	spontaneous	JJ	B-NP	O
return	return	NN	I-NP	O
of	of	IN	B-PP	O
vital	vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
AED	AED	NN	I-NP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
her	her	PRP	B-NP	O
and	and	CC	O	O
determined	determine	VBN	B-NP	O
pt	pt	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
shockable	shockable	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

AED	AED	VBN	B-VP	O
unfortunately	unfortunately	RB	B-ADVP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
print	print	VB	I-VP	O
any	any	DT	B-NP	O
strips	strip	NNS	I-NP	O
,	,	,	O	O
so	so	IN	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
no	no	DT	B-NP	O
record	record	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
incident	incident	NN	I-NP	O
.	.	.	O	O

MD	MD	NN	B-NP	O
at	at	IN	B-PP	O
Cord	Cord	NNP	B-NP	O
University	University	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
reports	report	NNS	I-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
cyanotic	cyanotic	JJ	B-ADJP	O
,	,	,	O	O
apenic	apenic	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
or	or	CC	O	O
raidal	raidal	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
by	by	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
auscultation	auscultation	NN	I-NP	O
.	.	.	O	O

MD	MD	NN	B-NP	O
reports	report	VBZ	B-VP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
skin	skin	NN	I-NP	O
color	color	NN	I-NP	O
improved	improve	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
with	with	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
adequate	adequate	JJ	B-NP	O
bag	bag	NN	I-NP	O
mask	mask	NN	I-NP	O
ventilation	ventilation	NN	I-NP	O
.	.	.	O	O

Whiel	Whiel	NN	B-NP	O
pt	pt	NN	I-NP	O
being	be	VBG	B-VP	O
moved	move	VBN	I-VP	O
from	from	IN	B-PP	O
chair	chair	NN	B-NP	O
to	to	TO	B-PP	O
ground	ground	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
HD	HD	NN	I-NP	O
access	access	NN	I-NP	O
was	be	VBD	B-VP	O
lost	lose	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
in	in	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
.	.	.	O	O

--	--	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
echo	echo	RB	B-ADVP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
of	of	IN	B-PP	O
1999	1999	CD	B-NP	O
shows	show	NNS	I-NP	O
moderate	moderate	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
of	of	IN	B-PP	O
about	about	RB	B-NP	O
65	65	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
20	20	CD	I-NP	O
years	year	NNS	I-NP	O
including	include	VBG	B-PP	O
with	with	IN	B-PP	O
retinopathy	retinopathy	NN	B-NP	O
,	,	,	O	O
nephropathy	nephropathy	NN	B-NP	O
and	and	CC	O	O
neuropathic	neuropathic	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
ypertension	ypertension	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
20	20	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
medullary	medullary	JJ	I-NP	O
CVA	CVA	NNP	I-NP	O
July	July	NNP	I-NP	O
1999	1999	CD	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
PICA	PICA	NNP	I-NP	O
resulting	result	VBG	B-VP	O
Wallenberg	Wallenberg	NNP	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
knee	knee	NN	B-NP	O
degenerative	degenerative	JJ	I-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
iron-deficiency	iron-deficiency	NN	B-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

--	--	:	B-NP	O
MEDS	MEDS	NNP	I-NP	O
AT	AT	NNP	I-NP	O
HOME	HOME	NNP	I-NP	O
:	:	:	O	O
Toprol	Toprol	NNP	B-NP	O
200	200	CD	B-NP	O
BID	BID	NNP	I-NP	O
Enalapril	Enalapril	NNP	I-NP	O
20	20	CD	I-NP	O
BID	BID	NNP	I-NP	O
Lispro	Lispro	NNP	I-NP	O
18	18	CD	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Insulin	Insulin	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
50U	50U	NNP	I-NP	O
qAM	qAM	NN	I-NP	O
Insulin	Insulin	NN	I-NP	O
NPH	NPH	NN	I-NP	O
25U	25U	NN	I-NP	O
qPM	qPM	NN	I-NP	O
Losartan	Losartan	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
qD	qD	NN	I-NP	O
Advair	Advair	NNP	I-NP	O
Discus	Discus	NNP	I-NP	O
Tramodol	Tramodol	NNP	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
q6	q6	NN	I-NP	O
prn	prn	NN	I-NP	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qD	qD	NN	I-NP	O
Oxycodone	Oxycodone	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
BID	BID	NN	I-NP	O
prn	prn	NN	I-NP	O
Amitryptilline	Amitryptilline	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
qPM	qPM	NN	I-NP	O
Nephrocaps	Nephrocap	NNS	I-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
qD	qD	NN	I-NP	O
--	--	:	O	O
STUDIES	STUDIES	NN	B-NP	O
:	:	:	O	O
ECHO	ECHO	NN	B-NP	B-DNA
7/23	7/23	CD	I-NP	I-DNA
showed	show	VBD	B-VP	O
LVEF	LVEF	NN	B-NP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
LVH	LVH	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
RWMA	RWMA	NN	I-NP	B-protein
ECHO	ECHO	NN	I-NP	I-protein
9/30/06	9/30/06	CD	I-NP	I-protein
:	:	:	O	O
nl	nl	NN	B-NP	O
LV	LV	NN	I-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
LV	LV	NN	I-NP	I-protein
functino	functino	NN	I-NP	I-protein
,	,	,	O	O
EF	EF	NN	B-NP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
RWMA	RWMA	NN	I-NP	B-protein
.	.	.	O	O

enlarged	enlarge	VBN	B-NP	O
RV	RV	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
LAE	LAE	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
RA	RA	NN	I-NP	I-protein
,	,	,	O	O
trave	trave	VBP	B-VP	O
MR	MR	NN	B-NP	B-protein
<	<	SYM	B-NP	O
mild	mild	JJ	I-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
study	study	NN	I-NP	O
in	in	IN	B-PP	O
8/18	8/18	CD	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
rhythm	rhythm	NN	B-NP	O
100	100	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
old	old	JJ	B-NP	O
T-wave	T-wave	NN	I-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	B-protein
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
PET	PET	NN	B-NP	O
perfusion	perfusion	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
1/17/06	1/17/06	CD	I-NP	O
:	:	:	O	O
Image	Image	NN	B-NP	O
quality	quality	NN	I-NP	O
was	be	VBD	B-VP	O
excellent	excellent	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
images	image	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
normal	normal	JJ	B-NP	O
LV	LV	NN	I-NP	O
size	size	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
tracer	tracer	NN	I-NP	O
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
mildly	mildly	RB	I-NP	O
dilated	dilate	VBN	I-NP	O
RV	RV	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
RV	RV	NN	I-NP	O
tracer	tracer	NN	I-NP	O
uptake	uptake	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
defects	defect	NNS	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
stress	stress	NN	I-NP	O
or	or	CC	I-NP	O
rest	rest	NN	I-NP	O
images	image	NNS	I-NP	O
.	.	.	O	O

normal	normal	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
,	,	,	O	O
LVEF	LVEF	NN	B-NP	O
72	72	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
RVH	RVH	NN	I-NP	O
CXR	CXR	NN	I-NP	O
3/22/06	3/22/06	CD	I-NP	O
:	:	:	O	O
PA	PA	NN	B-NP	O
and	and	CC	O	O
lateral	lateral	JJ	B-NP	O
films	film	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
right	right	JJ	B-NP	O
central	central	JJ	I-NP	O
line	line	NN	I-NP	O
at	at	IN	B-PP	O
SVC	SVC	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
degenerative	degenerative	JJ	B-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dorsal	dorsal	JJ	I-NP	O
spine	spine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
heart	heart	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
enlarged	enlarge	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	B-cell_type
infiltrates	infiltrate	NNS	I-NP	I-cell_type
or	or	CC	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
PROCEDURE	PROCEDURE	NN	B-NP	O
:	:	:	O	O
10/7/06	10/7/06	CD	B-NP	O
:	:	:	O	O
EP	EP	NN	B-NP	O
study	study	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
SA	SA	NN	I-NP	O
node	node	NN	I-NP	O
functino	functino	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
conduction	conduction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
tachyarrythmias	tachyarrythmia	NNS	I-NP	O
were	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
.	.	.	O	O

An	An	DT	B-NP	O
implanted	implant	VBN	I-NP	O
loop	loop	NN	I-NP	O
recorder	recorder	NN	I-NP	O
device	device	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Medtronic	Medtronic	NNP	I-NP	O
Reveal	Reveal	NNP	I-NP	O
Plus	Plus	NNP	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
plced	plce	VBN	I-VP	O
in	in	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
tolerated	tolerate	VBD	B-VP	O
procedure	procedure	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
complications	complication	NNS	I-NP	O
,	,	,	O	O
bleeding	bleeding	NN	B-NP	O
or	or	CC	I-NP	O
signs/sx	signs/sx	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
Exam	Exam	NN	I-NP	O
on	on	IN	B-PP	O
Admission	Admission	NN	B-NP	O
:	:	:	O	O
T99	T99	NN	B-NP	O
.3	.3	NN	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
110-120/50	110-120/50	CD	I-NP	O
-60	-60	CD	I-NP	O
P88-90R	P88-90R	NN	I-NP	O
O2	O2	NN	I-NP	O
98RA	98RA	NN	I-NP	O
Morbidly	Morbidly	RB	B-ADJP	O
obese	obese	JJ	I-ADJP	O
,	,	,	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
distant	distant	NN	B-NP	O
,	,	,	O	O
II/VI	II/VI	NNP	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
RUSB	RUSB	NNP	B-NP	B-protein
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
bibasilar	bibasilar	JJ	B-NP	O
crakles	crakle	NNS	I-NP	O
R	R	NN	I-NP	O
>	>	SYM	B-NP	O
L	L	NN	I-NP	O
,	,	,	O	O
distant	distant	JJ	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
large	large	JJ	B-NP	O
pannus	pannus	NN	I-NP	O
,	,	,	O	O
RUQ	RUQ	NN	B-NP	B-protein
scar	scar	NN	I-NP	I-protein
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
appy	appy	JJ	I-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
NT	NT	NN	I-NP	O
,	,	,	I-NP	O
ND	ND	NN	I-NP	O
,	,	,	I-NP	O
BS	BS	NN	I-NP	O
+	+	SYM	B-NP	O
.	.	.	O	O

Ext	Ext	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
brawny	brawny	JJ	I-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
feet	foot	NNS	I-NP	O
b/l	b/l	NN	I-NP	O
,	,	,	O	O
palpable	palpable	JJ	B-NP	O
thrill	thrill	NN	I-NP	O
on	on	IN	B-PP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
right	right	JJ	I-NP	O
distal	distal	JJ	I-NP	O
forearm	forearm	NN	I-NP	O
at	at	IN	B-PP	O
site	site	NN	B-NP	O
of	of	IN	B-PP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
a-v	a-v	JJ	I-NP	O
fistula	fistula	NN	I-NP	O
.	.	.	O	O

WWP	WWP	NN	B-NP	O
,	,	,	O	O
DP	DP	NN	B-NP	O
palpable	palpable	JJ	I-NP	O
b/l	b/l	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
alert	alert	JJ	B-ADJP	O
,	,	,	O	O
EOMI	EOMI	NNP	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
SIG	SIG	NN	B-NP	B-protein
LABS	LABS	NN	I-NP	I-protein
on	on	IN	B-PP	O
ADMISSION	ADMISSION	NN	B-NP	O
:	:	:	O	O
Na	Na	NN	B-NP	B-DNA
130	130	CD	I-NP	I-DNA
K	K	NN	I-NP	I-DNA
4.2	4.2	NN	I-NP	I-DNA
Cl	Cl	NN	I-NP	I-DNA
96	96	CD	B-NP	I-DNA
CO2	CO2	NN	I-NP	I-DNA
33	33	CD	B-NP	I-DNA
BUN	BUN	NN	I-NP	I-DNA
17	17	CD	B-NP	I-DNA
Cr	Cr	NNP	I-NP	I-DNA
5.5	5.5	CD	I-NP	I-DNA
Ca	Ca	NNP	I-NP	I-DNA
8.6	8.6	CD	I-NP	I-DNA
Mg	Mg	NNP	I-NP	I-DNA
1.5	1.5	CD	I-NP	I-DNA
CK104	CK104	NN	I-NP	I-DNA
CKMB	CKMB	NN	I-NP	I-DNA
0.6	0.6	CD	I-NP	I-DNA
TnI	TnI	NN	I-NP	I-DNA
<	<	SYM	B-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
6.8	6.8	CD	I-NP	O
Hct	Hct	NNP	I-NP	O
31.8	31.8	CD	I-NP	O
Plat	Plat	NNP	I-NP	O
166	166	CD	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
HOSPITAL	HOSPITAL	JJ	I-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
55F	55F	NN	I-NP	O
with	with	IN	B-PP	O
ESRD	ESRD	NN	B-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
2/2	2/2	CD	I-NP	I-protein
DM	DM	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
apparent	apparent	JJ	B-NP	O
syncopal	syncopal	JJ	I-NP	O
episode	episode	NN	I-NP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
HD	HD	NN	B-NP	O
on	on	IN	B-PP	O
7/12	7/12	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
presentation	presentation	NN	B-NP	O
to	to	TO	B-PP	O
4/11	4/11	CD	B-NP	O
episode	episode	NN	I-NP	O
from	from	IN	B-PP	O
recent	recent	JJ	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
Whether	Whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	B-VP	O
pt	pt	VB	I-VP	O
actually	actually	RB	B-ADVP	O
ever	ever	RB	B-ADVP	O
a	a	DT	B-NP	O
V-fib	V-fib	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
doubt	doubt	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
never	never	RB	I-VP	O
had	have	VBD	I-VP	O
an	an	DT	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
proper	proper	JJ	I-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
was	be	VBD	B-VP	O
warranted	warrant	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
differential	differential	JJ	I-NP	O
included	include	VBN	I-NP	O
arrythmia	arrythmia	NN	I-NP	O
vs	vs	IN	B-PP	O
obesity	obesity	NN	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pt	pt	NN	I-NP	O
reports	report	NNS	I-NP	O
OSA	OSA	NN	I-NP	O
sx	sx	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
hypoglycemia	hypoglycemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
HD-related	HD-related	JJ	B-NP	O
hypotension	hypotension	NN	I-NP	O
.	.	.	O	O

Ischemia	Ischemia	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
serial	serial	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
enzymes	enzyme	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
asa	asa	NN	B-NP	O
,	,	,	O	O
bb	bb	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
statin	statin	NN	B-NP	O
and	and	CC	I-NP	O
NTG	NTG	NN	I-NP	O
prn	prn	NN	I-NP	O
while	while	IN	B-SBAR	O
ruling	rule	VBG	B-VP	O
out	out	RP	B-PRT	O
ischemic	ischemic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
anticipation	anticipation	NN	B-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
EP	EP	NN	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

PET	PET	NN	B-NP	O
perfusion	perfusion	NN	I-NP	O
scan	scan	NN	I-NP	O
for	for	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
showing	show	VBG	B-VP	O
normal	normal	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
.	.	.	O	O

Pump	Pump	NNP	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
not	not	RB	B-VP	O
appreciated	appreciate	VBN	I-VP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
prior	prior	JJ	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
diuretic	diuretic	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
kept	keep	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
BB	BB	NN	I-NP	O
,	,	,	O	O
CCB	CCB	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
ACEi	ACEi	NN	I-NP	O
to	to	TO	B-PP	O
goal	goal	NN	B-NP	O
SBP	SBP	NN	I-NP	O
<	<	SYM	B-NP	O
120	120	CD	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
for	for	IN	B-PP	O
arrythmia	arrythmia	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
floor	floor	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
events	event	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
given	give	VBN	B-PP	O
history	history	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	B-protein
lab	lab	NN	I-NP	I-protein
for	for	IN	B-PP	O
EP	EP	NN	B-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
4/19/06	4/19/06	CD	B-NP	O
.	.	.	O	O

EPS	EPS	NNS	B-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
conduction	conduction	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
SA	SA	NN	I-NP	O
node	node	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
so	so	RB	B-ADVP	O
a	a	DT	B-NP	O
loop	loop	NN	I-NP	O
recorder	recorder	NN	I-NP	O
device	device	NN	I-NP	O
was	be	VBD	B-VP	O
implanted	implant	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
HR	HR	NN	I-NP	O
and	and	CC	I-NP	O
record	record	NN	I-NP	O
if	if	IN	B-SBAR	O
HR	HR	NN	B-NP	B-protein
>	>	SYM	B-VP	O
or	or	CC	O	O
<	<	JJR	B-NP	O
parameters	parameter	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
pt	pt	NN	B-NP	O
triggers	trigger	VBZ	B-VP	O
device	device	NN	B-NP	O
to	to	TO	B-PP	O
record	record	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
signs/sx	signs/sx	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleeding	NN	B-NP	O
,	,	,	O	O
infectino	infectino	NN	B-NP	O
,	,	,	O	O
hematoma	hematoma	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
discharged	discharge	VBD	B-VP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
after	after	IN	B-PP	O
HD	HD	NN	B-NP	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
ESRD	ESRD	NN	B-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
HD	HD	NN	I-NP	O
on	on	IN	B-PP	O
Wed	Wed	NNP	B-NP	O
and	and	CC	I-NP	O
Sat	Sat	NNP	I-NP	O
am	am	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
difficulty	difficulty	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
EPO	EPO	NN	B-NP	B-protein
10	10	CD	I-NP	O
,	,	,	O	O
000U	000U	NN	B-NP	O
qHD	qHD	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
tunneled	tunnel	VBN	I-VP	O
line	line	NN	B-NP	O
in	in	IN	B-PP	O
Right	Right	NN	B-NP	B-protein
IJ	IJ	NN	I-NP	I-protein
for	for	IN	B-PP	O
access	access	NN	B-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
Anemia	Anemia	NN	B-NP	O
:	:	:	O	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
ESRD	ESRD	NN	B-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
Hct	Hct	NNP	I-NP	O
around	around	IN	B-PP	O
30	30	CD	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
on	on	IN	B-PP	O
epogen	epogen	NN	B-NP	O
.	.	.	O	O

Anemia	Anemia	NN	B-NP	O
studies	study	NNS	I-NP	O
WNL	WNL	NNP	B-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
Diabetes	Diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
Long	Long	JJ	B-NP	O
and	and	CC	I-NP	O
short-acting	short-acting	JJ	I-NP	B-protein
SC	SC	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

BID	BID	NN	B-NP	O
NPH	NPH	NN	I-NP	O
started	start	VBD	B-VP	O
at	at	IN	B-PP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
while	while	IN	B-SBAR	O
oral	oral	JJ	B-NP	O
diet	diet	NN	I-NP	O
is	be	VBZ	B-VP	O
held	hold	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
lower	low	JJR	B-NP	O
sliding	slide	VBG	I-NP	O
scales	scale	NNS	I-NP	O
,	,	,	O	O
due	due	JJ	B-PP	O
to	to	TO	I-PP	O
significant	significant	JJ	B-NP	O
parts	part	NNS	I-NP	O
os	o	NNS	I-NP	O
stay	stay	VBP	B-VP	O
where	where	WRB	B-ADVP	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
NPO	NPO	NN	B-NP	B-protein
for	for	IN	B-PP	O
procedures	procedure	NNS	B-NP	O
.	.	.	O	O

Wil	Wil	NNP	B-NP	O
lbe	lbe	NN	I-NP	O
discharged	discharge	VBD	B-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
reports	report	VBZ	B-VP	O
4	4	CD	B-NP	O
day	day	NN	I-NP	O
h/o	h/o	NN	I-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
afebrile	afebrile	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
on	on	IN	B-PP	O
HD6	HD6	NN	B-NP	B-protein
,	,	,	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
eleavtion	eleavtion	NN	B-NP	O
in	in	IN	B-PP	O
WBC	WBC	NN	B-NP	B-cell_type
-LRB-	-LRB-	HYPH	B-NP	O
6.9	6.9	CD	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
12	12	CD	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
,	,	,	O	O
however	however	RB	B-NP	O
pt	pt	NN	I-NP	O
afebrile	afebrile	JJ	I-NP	O
,	,	,	I-NP	O
asymptomatic	asymptomatic	JJ	I-NP	O
,	,	,	I-NP	O
CXR	CXR	NN	I-NP	B-protein
shows	show	VBZ	B-VP	O
no	no	DT	B-NP	O
infiltrative	infiltrative	JJ	I-NP	O
process	process	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
renally	renally	RB	B-VP	O
dosed	dose	VBN	I-VP	O
.	.	.	O	O

DERM	DERM	NN	B-NP	O
:	:	:	O	O
Brawny	Brawny	NNP	B-NP	O
skin	skin	NN	I-NP	O
changes	change	NNS	I-NP	O
:	:	:	O	O
Lac	Lac	NN	B-NP	O
Hydrin	Hydrin	NN	I-NP	O
started	start	VBD	B-VP	O
.	.	.	O	O

Candidiasis	Candidiasis	NN	B-NP	O
noted	note	VBD	B-VP	O
in	in	IN	B-PP	O
folds	fold	NNS	B-NP	O
between	between	IN	B-PP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
pannus	pannus	NN	I-NP	O
and	and	CC	I-NP	O
groin	groin	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
%	%	NN	I-NP	O
Miconazole	Miconazole	NN	I-NP	O
topical	topical	JJ	I-NP	O
poder	poder	NN	I-NP	O
started	start	VBD	B-VP	O
PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
PT	PT	NN	B-NP	O
received	receive	VBD	B-VP	O
heparin	heparin	NN	B-NP	O
SC	SC	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Nexium	Nexium	NN	B-NP	O
,	,	,	O	O
wil	wil	NN	B-NP	O
be	be	VB	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
protonix	protonix	NN	B-NP	O
.	.	.	O	O

Code	Code	NNP	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
Full	Full	NNP	B-NP	O
Code	Code	NNP	I-NP	O
.	.	.	O	O

Health	Health	NNP	B-NP	O
care	care	NN	I-NP	O
proxy	proxy	NN	I-NP	O
is	be	VBZ	B-VP	O
Brain	Brain	NNP	B-NP	O
Bruess	Bruess	NNP	I-NP	O
325-446-2221	325-446-2221	CD	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNP	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
unresponsive	unresponsive	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
looked	look	VBD	B-VP	O
at	at	IN	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
and	and	CC	O	O
put	put	VB	B-VP	O
a	a	DT	B-NP	O
recorder	recorder	NN	I-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
chest	chest	NN	I-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
irregular	irregular	JJ	I-NP	O
heartbeats	heartbeat	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
appointments	appointment	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
return	return	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
notice	notice	VBP	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
pass	pass	VBP	B-VP	O
out	out	RP	B-PRT	O
again	again	RB	B-ADVP	O
.	.	.	O	O

YOu	YOu	PRP	B-NP	B-cell_type
have	have	VBP	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
referred	refer	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
sleep	sleep	NN	I-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
your	your	PRP$	B-NP	O
obstructive	obstructive	JJ	I-NP	O
sleep	sleep	JJ	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
make	make	VBP	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
them	them	PRP	B-NP	O
if	if	IN	B-SBAR	O
they	they	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
contact	contact	VB	I-VP	O
you	you	PRP	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	HYPH	O	O
We	We	PRP	B-NP	O
recommend	recommend	VBP	B-VP	O
pt	pt	JJ	B-NP	O
get	get	NN	I-NP	O
outpt	outpt	JJ	I-NP	O
polysomnography	polysomnography	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
for	for	IN	B-PP	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
potential	potential	JJ	B-NP	O
fitting	fitting	NN	I-NP	O
for	for	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
.	.	.	O	O

Referral	Referral	JJ	B-NP	O
placed	place	VBN	I-NP	O
,	,	,	I-NP	O
pt	pt	NN	I-NP	O
will	will	MD	B-VP	O
receive	receive	VB	I-VP	O
call	call	NN	B-NP	O
from	from	IN	B-PP	O
Torsba	Torsba	NNP	B-NP	O
Dicli	Dicli	NNP	I-NP	O
Errey	Errey	NNP	I-NP	O
Center	Center	NNP	I-NP	O
6	6	CD	I-NP	O
-	-	HYPH	B-NP	O
754-443-2399	754-443-2399	CD	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
appointment	appointment	NN	B-NP	O
for	for	IN	B-PP	O
sleep	sleep	JJ	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
BP	BP	NN	I-NP	O
and	and	CC	I-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ANtibiotics	ANtibiotic	NNPS	I-NP	O
:	:	:	O	O
continue	continue	VB	B-VP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
3	3	CD	I-NP	O
day	day	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
additino	additino	NN	B-NP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
day	day	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Levofloxacin	Levofloxacin	NN	B-NP	O
dosed	dose	VBN	B-VP	O
renally	renally	RB	B-ADVP	O
for	for	IN	B-PP	O
broader	broad	JJR	B-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
started	start	VBD	B-VP	O
mild	mild	JJ	B-NP	O
keratolytic	keratolytic	JJ	I-NP	O
Lac-Hydrin	Lac-Hydrin	NN	I-NP	O
top	top	JJ	I-NP	O
BID	BID	NN	I-NP	O
for	for	IN	B-PP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
brawny	brawny	JJ	I-NP	O
skin	skin	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
short	short	JJ	I-NP	O
course	course	NN	I-NP	O
miconazole	miconazole	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
for	for	IN	B-PP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
candidal	candidal	JJ	I-NP	O
nifectino	nifectino	NN	I-NP	O
in	in	IN	B-PP	O
groin	groin	NN	B-NP	O
skin	skin	NN	I-NP	O
folds	fold	VBZ	B-VP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DUCKWALL	DUCKWALL	NNP	B-NP	O
,	,	,	O	O
CHAD	CHAD	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EU248	EU248	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/6/06	8/6/06	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

